Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/41945
Title: Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.
Authors: 
Mesh: 
Issue Date: 3-Oct-2017
Citation: Ann. Intern. Med..2017 Oct;(167)7:449-455
Abstract: The ERSPC (European Randomized Study of Screening for Prostate Cancer) found that screening reduced prostate cancer mortality, but the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) found no reduction.
PMID: 28869989
URI: https://hdl.handle.net/20.500.12530/41945
Rights: openAccess
Appears in Collections:Hospitales > H. U. Infanta Cristina > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Puerta de Hierro-Segovia de Arana > Artículos

Files in This Item:
File Description SizeFormat 
PMC5734053.pdf225.86 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.